Summary
The chorus of disapproval about the cost of EpiPen prescriptions reached a crescendo last week after the maker of the drug, Mylan, was widely lambasted for drastic price increases in the product which is widely used to combat potentially life-threatening allergic reactions. Over the past decade, the list price for a package of two injectors has jumped from $94 to $608; Mylan raised the price by 15 percent three separate times since 2014. The EpiPen has garnered more attention recently thanks, in part, to timing: with the beginning of the school year, many parents suddenly found that the device cost more than ever before.